_ Children's HealthImmunotherapy Better than Chemotherapy for Some Kids with Leukemia By Jane Farrell articleResearchers have found that treatment with an immunotherapy drug is superior to standard chemotherapy for children with leukemia that has … Read More→
_ Breast cancer Breast Cancer Treatment OptionsBreaking News: First Immunotherapy Success for Triple-Negative Breast Cancer By Sondra Forsyth articleResearch led by Queen Mary University of London and St Bartholomew’s Hospital in London shows for the first time that … Read More→
_ Skin Skin HealthThe Latest on Melanoma Treatments By articleEditor’s Note: According to the American Academy of Dermatology (AAD), melanoma is the deadliest form of skin cancer, accounting for … Read More→
_ Breast CancerImmunotherapy in Early-Stage Breast Cancer By Sondra Forsyth articleYale Cancer Center researchers used a new molecular analysis tool to accurately detect the level of an important target for immunotherapy in early-stage breast cancers. The diagnostic test, using RNAScope, measures the amount of PD-L1 (programmed death ligand 1) mRNA in routine formalin-fixed cancer tissues and is devoid of many of the technical issues that plague antibody-based detection methods that have yielded conflicting results in the past. PD-L1 is the target of several novel immune stimulatory therapies in clinical trials.